1. Home
  2. ZLAB vs CUBI Comparison

ZLAB vs CUBI Comparison

Compare ZLAB & CUBI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ZLAB
  • CUBI
  • Stock Information
  • Founded
  • ZLAB 2013
  • CUBI 1994
  • Country
  • ZLAB China
  • CUBI United States
  • Employees
  • ZLAB N/A
  • CUBI N/A
  • Industry
  • ZLAB Biotechnology: Pharmaceutical Preparations
  • CUBI Major Banks
  • Sector
  • ZLAB Health Care
  • CUBI Finance
  • Exchange
  • ZLAB Nasdaq
  • CUBI Nasdaq
  • Market Cap
  • ZLAB 3.6B
  • CUBI 1.7B
  • IPO Year
  • ZLAB 2017
  • CUBI 2012
  • Fundamental
  • Price
  • ZLAB $35.00
  • CUBI $59.54
  • Analyst Decision
  • ZLAB Buy
  • CUBI Buy
  • Analyst Count
  • ZLAB 5
  • CUBI 10
  • Target Price
  • ZLAB $54.28
  • CUBI $65.67
  • AVG Volume (30 Days)
  • ZLAB 1.0M
  • CUBI 256.4K
  • Earning Date
  • ZLAB 08-05-2025
  • CUBI 07-24-2025
  • Dividend Yield
  • ZLAB N/A
  • CUBI N/A
  • EPS Growth
  • ZLAB N/A
  • CUBI N/A
  • EPS
  • ZLAB N/A
  • CUBI 3.98
  • Revenue
  • ZLAB $418,326,000.00
  • CUBI $591,500,000.00
  • Revenue This Year
  • ZLAB $44.07
  • CUBI $12.34
  • Revenue Next Year
  • ZLAB $49.13
  • CUBI $10.08
  • P/E Ratio
  • ZLAB N/A
  • CUBI $14.81
  • Revenue Growth
  • ZLAB 43.72
  • CUBI N/A
  • 52 Week Low
  • ZLAB $16.01
  • CUBI $40.75
  • 52 Week High
  • ZLAB $44.34
  • CUBI $68.49
  • Technical
  • Relative Strength Index (RSI)
  • ZLAB 51.28
  • CUBI 74.03
  • Support Level
  • ZLAB $34.44
  • CUBI $51.61
  • Resistance Level
  • ZLAB $38.18
  • CUBI $51.55
  • Average True Range (ATR)
  • ZLAB 1.33
  • CUBI 1.41
  • MACD
  • ZLAB -0.44
  • CUBI 0.68
  • Stochastic Oscillator
  • ZLAB 17.66
  • CUBI 98.16

About ZLAB Zai Lab Limited

Zai Lab Ltd is a biopharmaceutical company focusing on discovering or licensing, developing, and commercializing proprietary therapeutics that address areas of unmet medical need including in the fields of oncology, autoimmune and infectious diseases. The pipeline of proprietary drug candidates of the company includes ZL-1218 (CCR8) Solid Tumors, ZL-1310 (DLL3 ADC) ES-SCLC Other NECs, ZL-6301 (ROR1 ADC) Solid Tumors, ZL 6201 (LRRC15 ADC) Solid Tumors.

About CUBI Customers Bancorp Inc

Customers Bancorp Inc is a bank holding company engaged in banking activities. It provides financial products and services to small and middle-market businesses, not-for-profits, and consumers. The company operates in Lending Activities, Commercial Lending, Consumer Lending, Private Banking, Deposit Products, Other Funding Sources and Financial Products and Services. The majority of revenue is derived from commercial lending.

Share on Social Networks: